Ohio Public Employees Retirement System (OPERS)’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNE
PA
DA
DAM
HVC
Ohio Public Employees Retirement System (OPERS)'s VYNE Position: Q1 2021 in Review
Ohio Public Employees Retirement System (OPERS) sold out of VYNE Therapeutics (VYNE) in Q1 2021, closing a stake of 18 shares — an estimated $105K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in VYNE in Q1 2019 and held it in 8 quarters. The position peaked at $105K in Q4 2020. 81 funds tracked by Wall St. Rank hold VYNE as of Q1 2021.
- Ohio Public Employees Retirement System (OPERS) reported no remaining VYNE Therapeutics position as of Q1 2021 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 18 VYNE Therapeutics shares in Q1 2021, an estimated $105K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in VYNE Therapeutics in Q1 2019 and held it in 8 quarters.
- Ohio Public Employees Retirement System (OPERS)'s VYNE Therapeutics position peaked at $105K in Q4 2020.
- 81 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q1 2021.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2021, filed 14 May 2021.